CLARI Stock Overview
Provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
Clariane SE Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.86 |
52 Week High | €5.45 |
52 Week Low | €1.32 |
Beta | 0.96 |
1 Month Change | 0.65% |
3 Month Change | 6.04% |
1 Year Change | -24.39% |
3 Year Change | -93.29% |
5 Year Change | -95.56% |
Change since IPO | -94.88% |
Recent News & Updates
Revenues Tell The Story For Clariane SE (EPA:CLARI) As Its Stock Soars 26%
Nov 05Here's Why Clariane (EPA:CLARI) Has A Meaningful Debt Burden
Sep 13Recent updates
Revenues Tell The Story For Clariane SE (EPA:CLARI) As Its Stock Soars 26%
Nov 05Here's Why Clariane (EPA:CLARI) Has A Meaningful Debt Burden
Sep 13Clariane SE's (EPA:CLARI) 26% Cheaper Price Remains In Tune With Revenues
Aug 06Here's Why It's Unlikely That Clariane SE's (EPA:CLARI) CEO Will See A Pay Rise This Year
Jun 04Clariane SE (EPA:CLARI) Shares Could Be 33% Below Their Intrinsic Value Estimate
May 22Market Participants Recognise Clariane SE's (EPA:CLARI) Revenues Pushing Shares 187% Higher
May 22Clariane (EPA:CLARI) Takes On Some Risk With Its Use Of Debt
Apr 28Is It Too Late To Consider Buying Clariane SE (EPA:CLARI)?
Dec 06These 4 Measures Indicate That Clariane (EPA:CLARI) Is Using Debt Extensively
Oct 31Calculating The Fair Value Of Clariane SE (EPA:CLARI)
Sep 21What Is Clariane SE's (EPA:CLARI) Share Price Doing?
Jul 29At €6.98, Is It Time To Put Korian (EPA:KORI) On Your Watch List?
Apr 04These 4 Measures Indicate That Korian (EPA:KORI) Is Using Debt Extensively
Mar 16A Look At The Fair Value Of Korian (EPA:KORI)
Jan 16Should You Think About Buying Korian (EPA:KORI) Now?
Dec 26Does Korian (EPA:KORI) Have A Healthy Balance Sheet?
Dec 01Is There Now An Opportunity In Korian (EPA:KORI)?
Sep 26Is Korian (EPA:KORI) A Risky Investment?
Aug 31Why Korian (EPA:KORI) Could Be Worth Watching
Jun 14We Think Korian (EPA:KORI) Is Taking Some Risk With Its Debt
Mar 30Korian (EPA:KORI) Has A Somewhat Strained Balance Sheet
Dec 24Korian (EPA:KORI) Seems To Be Using A Lot Of Debt
Sep 25Why Korian (EPA:KORI) Could Be Worth Watching
Jul 15Shareholder Returns
CLARI | FR Healthcare | FR Market | |
---|---|---|---|
7D | -1.8% | 3.4% | -0.8% |
1Y | -24.4% | -44.6% | -4.6% |
Return vs Industry: CLARI exceeded the French Healthcare industry which returned -44.6% over the past year.
Return vs Market: CLARI underperformed the French Market which returned -4.6% over the past year.
Price Volatility
CLARI volatility | |
---|---|
CLARI Average Weekly Movement | 8.5% |
Healthcare Industry Average Movement | 5.6% |
Market Average Movement | 4.5% |
10% most volatile stocks in FR Market | 9.7% |
10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: CLARI's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: CLARI's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 60,000 | Sophie Boissard | www.clariane.com |
Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Clariane SE Fundamentals Summary
CLARI fundamental statistics | |
---|---|
Market cap | €662.04m |
Earnings (TTM) | -€128.93m |
Revenue (TTM) | €5.17b |
0.1x
P/S Ratio-5.1x
P/E RatioIs CLARI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLARI income statement (TTM) | |
---|---|
Revenue | €5.17b |
Cost of Revenue | €3.50b |
Gross Profit | €1.67b |
Other Expenses | €1.80b |
Earnings | -€128.93m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 24, 2025
Earnings per share (EPS) | -0.36 |
Gross Margin | 32.25% |
Net Profit Margin | -2.49% |
Debt/Equity Ratio | 111.1% |
How did CLARI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 19:54 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Clariane SE is covered by 22 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Armelle Moulin | AlphaValue |
Fraser Donlon | Berenberg |
Laurent Gelebart | BNP Paribas Exane |